Using flow cytometry to evaluate the potential of targeting the "ERK1/2-STATS3-MCL-1 axis as a therapeutic strategy to overcome chemoresistance in acute myeloid leukaemia

Project Details

Description

Using flow cytometry to evaluate the potential of targeting the "ERK1/2-STATS3-MCL-1 axis as a therapeutic strategy to overcome chemoresistance in acute myeloid leukaemia
Short titleFlow cytometer for assessing the impact of a new therapaeutic strategy in Acute myeloid leukaemia
StatusFinished
Effective start/end date12/02/2012/02/21

Funding

  • Tenovus Scotland: £20,000.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 17 - Partnerships for the Goals

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.